Who is this course for?
Qualified and experienced mental healthcare professionals, including Authorised Prescribers and their teams, and therapists involved in ongoing or upcoming clinical trials.
A collaboration between MAPS and the Clinical Psychedelic Lab at Monash University, this training program prepares mental healthcare professionals to support MDMA-assisted psychotherapy for PTSD. It combines online learning with a week-long in-person residential intensive and is limited to 65 trainees.
Psychedelic Support
English
Next cohort: Jun 1, 2026
100 Hours
Start date: June 1, 2026
The MAPS International MDMA-assisted Therapy Training Program is a collaborative training offered by the Multidisciplinary Association for Psychedelic Studies (MAPS) and the Clinical Psychedelic Lab at Monash University. It is designed for qualified mental healthcare professionals seeking training in the safe and effective delivery of MDMA-assisted psychotherapy for PTSD. The program includes live presentations, video case presentations, discussions, scenario-based learning, self-reflection activities, group activities, online coursework, and creative projects. It covers fundamental processes, therapeutic alliances, and personal growth practices relevant to investigational MDMA-assisted therapy. The course runs over approximately 90 hours and combines asynchronous online material, live online seminars, and a 7-day residential intensive. The source states that the course is not currently being offered.
Qualified and experienced mental healthcare professionals, including Authorised Prescribers and their teams, and therapists involved in ongoing or upcoming clinical trials.
Qualified and experienced mental healthcare professionals; the source does not specify additional entry requirements.
Psychedelic Support is an online education and therapeutic platform offering accredited continuing education, online courses, and a vetted directory of licensed healthcare providers and community groups focused on psychedelic integration, harm reduction, and clinical referrals. It was founded in March 2018 to advance legal psychedelic-assisted therapies and professional training. ([psychedelic.support](https://psychedelic.support/our-story/))
Qualified and experienced mental healthcare professionals, including Authorised Prescribers and their teams, and therapists involved in ongoing or upcoming clinical trials.
Qualified and experienced mental healthcare professionals; the source does not specify additional entry requirements.
Format: Hybrid. Time commitment: 100 Hours.
The listed price is $7,650. Confirm the latest tuition, fees, and payment options with [object Object].
The listing includes a certificate signal. Accreditation note: CME. Confirm credential eligibility directly with the provider before enrolling.
The listed next cohort date is 2026-06-01.
The current listing status is Active. Use the provider website for the latest enrollment status.
By SoundMind
Shares course skills and categories
SoundMind Psychedelic Facilitator Training is an 8-month certificate program for Oregon psilocybin facilitator training. It covers psychedelic-assisted therapy topics, including ketamine, psilocybin, and MDMA in therapeutic settings.
Next cohort: Sep 1, 2026
Delivery: Online + United States
Includes medicine self-experience
By Therapsil
Shares course skills and categories
Fundamentals of MDMA-Assisted Psychotherapy is a training course on safely and effectively guiding clients through therapeutic MDMA experiences. It includes live seminars, experiential retreats, and integration practice in in-person or online formats.
Next cohort: Aug 2, 2026
Source lists: 122 hours
Delivery: Online + Vancouver, Canada + Canada
Includes medicine self-experience
By Fluence
Shares course skills and categories
A professional certificate program in psychedelic-assisted therapies and research offered by CIIS. It covers clinical and research foundations including pharmacology, research design, therapist competencies, and cultural and historical context.
Next cohort: Jun 1, 2026